❌

Normal view

Coupled Variational Reinforcement Learning for Language Model General Reasoning

arXiv:2512.12576v3 Announce Type: replace-cross Abstract: While reinforcement learning has achieved impressive progress in language model reasoning, it is constrained by the requirement for verifiable rewards. Recent verifier-free RL methods address this limitation by utilizing the probabilities that LLMs generate reference answers as reward signals. However, these approaches typically sample reasoning traces conditioned only on the question. This design decouples reasoning-trace sampling from answer information, leading to inefficient exploration and incoherence between traces and final answers. In this paper, we propose \textit{\b{Co}upled \b{V}ariational \b{R}einforcement \b{L}earning} (CoVRL), which bridges variational inference and reinforcement learning by coupling prior and posterior distributions through a hybrid sampling strategy. By constructing and optimizing a composite distribution that integrates these two distributions, CoVRL enables efficient exploration while preserving strong thought-answer coherence. Extensive experiments on mathematical and general reasoning benchmarks show that CoVRL improves performance by 12.4\% over the base model and achieves an additional 2.3\% improvement over state-of-the-art verifier-free RL baselines, providing a principled framework for enhancing the general reasoning capabilities of language models.

Unlocking the Future of Hepatocellular Carcinoma Early Diagnosis: The Promise of Extracellular Vesicle Biomarkers

25 May 2026 at 18:00

J Clin Transl Hepatol. 2026 Apr 28;14(4):462-477. doi: 10.14218/JCTH.2025.00589. Epub 2026 Apr 8.

ABSTRACT

Hepatocellular carcinoma (HCC) is one of the most prevalent and aggressive malignant tumors globally, with a notably low five-year survival rate. Its high mortality is largely attributed to challenges in early detection. Extracellular vesicles (EVs) are naturally occurring nanoparticles secreted by nearly all cell types and carry a diverse array of bioactive molecules, including proteins, nucleic acids (particularly non-coding RNAs), and lipids. EVs play pivotal roles in remodeling the tumor microenvironment and driving cancer progression through intercellular communication. Accumulating evidence has established that EVs are critically involved in the pathogenesis of HCC and are emerging as promising biomarkers for its early detection. With advances in EV isolation technologies, these vesicles have garnered considerable attention in the field of liquid biopsy for HCC. This review provides a comprehensive overview of the diagnostic potential of EV-derived biomarkers in HCC, including DNA, RNA, proteins, and lipids. Additionally, it discusses the advantages of integrating multi-omics approaches for HCC diagnosis. Furthermore, the review highlights the technical challenges in EV isolation and characterization, as well as the crucial role of reference genes in the standardization of EV data. These insights underscore the potential of EVs as novel, minimally invasive liquid biopsy biomarkers for the early diagnosis of HCC.

PMID:42181837 | PMC:PMC13195390 | DOI:10.14218/JCTH.2025.00589

❌